Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Simulation of Non-Pharmaceutical Interventions on COVID-19 with an Agent-based Model of Zonal Restraint

Lindsay Álvarez, Sergio Rojas-Galeano
doi: https://doi.org/10.1101/2020.06.13.20130542
Lindsay Álvarez
1School of Engineering, Universidad Distrital Francisco José de Caldas, Bogotá, Colombia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: srojas@udistrital.edu.co lalvarez@udistrital.edu.co
Sergio Rojas-Galeano
1School of Engineering, Universidad Distrital Francisco José de Caldas, Bogotá, Colombia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: srojas@udistrital.edu.co lalvarez@udistrital.edu.co
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Non-Pharmaceutical Interventions (NPI) are currently the only mechanism governments can use to mitigate the impact of the COVID-19 epidemic. Similarly to the actual spread of the disease, the dynamics of the contention patterns emerging from the application of NPIs are complex and depend on interactions between people within a specific region as well as other stochastic factors associated to demographic, geographic, political and economical conditions. Agent-based models simulate microscopic rules of simultaneous spatial interactions between multiple agents within a population, in an attempt to reproduce the complex dynamics of the effect of the contention measures. In this way, it is possible to design individual behaviours along with NPI scenarios, measuring how the simulation dynamics is affected and therefore, yielding rapid insights to perform a broad assessment of the potential of composite interventions at different stages of the epidemic. In this paper we describe a model and a tool to experiment with such kind of analysis applied to a conceptual city, considering a number of widely-applied NPIs such as social distancing, case isolation, home quarantine, total lockdown, sentinel testing, mask wearing and a distinctive “zonal” enforcement measure, requiring these interventions to be applied gradually to separated enclosed districts (zones). We find that the model is able to capture emerging dynamics associated to these NPIs; besides, the zonal contention strategy yields an improvement on the mitigation impact across all scenarios of combination with individual NPIs. The model and tool are open to extensions to account for omitted or newer factors affecting the planning and design of NPIs intended to counter the late stages or forthcoming waves of the COVID-19 crisis.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The authors received no specific funding for this work.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

IRB and/or ethics committee was not necessary.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Experiment data is available upon request. The software is publicly available at http://modelingcommons.org/browse/one_model/6374

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted June 16, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Simulation of Non-Pharmaceutical Interventions on COVID-19 with an Agent-based Model of Zonal Restraint
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Simulation of Non-Pharmaceutical Interventions on COVID-19 with an Agent-based Model of Zonal Restraint
Lindsay Álvarez, Sergio Rojas-Galeano
medRxiv 2020.06.13.20130542; doi: https://doi.org/10.1101/2020.06.13.20130542
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Simulation of Non-Pharmaceutical Interventions on COVID-19 with an Agent-based Model of Zonal Restraint
Lindsay Álvarez, Sergio Rojas-Galeano
medRxiv 2020.06.13.20130542; doi: https://doi.org/10.1101/2020.06.13.20130542

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (161)
  • Allergy and Immunology (416)
  • Anesthesia (91)
  • Cardiovascular Medicine (860)
  • Dentistry and Oral Medicine (159)
  • Dermatology (97)
  • Emergency Medicine (250)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (394)
  • Epidemiology (8562)
  • Forensic Medicine (4)
  • Gastroenterology (384)
  • Genetic and Genomic Medicine (1753)
  • Geriatric Medicine (167)
  • Health Economics (373)
  • Health Informatics (1244)
  • Health Policy (621)
  • Health Systems and Quality Improvement (468)
  • Hematology (196)
  • HIV/AIDS (374)
  • Infectious Diseases (except HIV/AIDS) (10303)
  • Intensive Care and Critical Care Medicine (553)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (212)
  • Neurology (1678)
  • Nursing (97)
  • Nutrition (251)
  • Obstetrics and Gynecology (326)
  • Occupational and Environmental Health (451)
  • Oncology (929)
  • Ophthalmology (263)
  • Orthopedics (102)
  • Otolaryngology (172)
  • Pain Medicine (114)
  • Palliative Medicine (40)
  • Pathology (253)
  • Pediatrics (536)
  • Pharmacology and Therapeutics (253)
  • Primary Care Research (208)
  • Psychiatry and Clinical Psychology (1770)
  • Public and Global Health (3841)
  • Radiology and Imaging (624)
  • Rehabilitation Medicine and Physical Therapy (320)
  • Respiratory Medicine (520)
  • Rheumatology (208)
  • Sexual and Reproductive Health (168)
  • Sports Medicine (158)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (76)